SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 20, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $302K total
Actionable Insight • Neutral

The insider sales are too small to signal a material change in outlook. Monitor for any upcoming clinical data readouts or regulatory catalysts that could drive the stock, as the company is a clinical-stage biotech. The CEO's sale may be routine portfolio diversification.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$27.52
T+0 close · Jul 20, 2026 · via day close
Latest settled
−23.69%
T+60 · $21.00
Vs SPY
−27.66%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 21 $27.52entry
  2. T+1 · 4mo ago −1.85%α −1.74% · $27.01
  3. T+5 · 4mo ago −1.13%α +0.10% · $27.21
  4. T+20 · 3mo ago −3.31%α −5.87% · $26.61
  5. T+60 · 5w ago −23.69%α −27.66% · $21.00
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Jon Congleton and CMO David Malcom Rodman sold a combined ~$302K in MLYS stock over a 7-day window, with the CEO's $291K sale representing the bulk. The sales are modest relative to the $2.2B market cap (~0.014%), and the CMO's trades include a same-day derivative exercise and sale, suggesting tax-related or liquidity-driven selling rather than a bearish signal. The cluster is small in dollar terms and lacks the materiality to indicate informed selling.

Key Financial Metrics

Direction
selling
Total Value
$302.0K
Insiders
2

Key Facts

  • CEO Jon Congleton sold 10,700 shares for ~$291K on 2026-07-13
  • CMO David Malcom Rodman sold 416 shares for ~$11K on 2026-07-17, following a derivative exercise
  • Total insider sales of ~$302K represent ~0.014% of MLYS's $2.2B market cap
  • CMO also exercised 416 derivative shares at $15.44 on 2026-07-17, a non-cash event
  • No open-market insider purchases were reported in the cluster window

Financial Impact

Insider sales of ~$302K are immaterial relative to $2.2B market cap

insider ownership

Risk Factors

  • Insider selling, while small, could be perceived negatively by retail investors
  • Clinical-stage biotech risk: no approved products, reliance on pipeline success

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MLYS-1784595659581

Track record

35 reports on MLYS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.

Filters
  1. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
  2. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
  3. Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
  4. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
  6. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  7. Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
  8. Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
  9. Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
  10. Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
Showing 10 of 35

US Market Status

Market Closed · Opens in 8h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026